• A human neutrophil interacting with Klebsiella pneumoniae.
    Biomarkers found for next ‘superbug’
    7/6/18

    A companion paper calls the UB discovery “a major step forward” in defining hypervirulent Klebsiella pneumoniae.

  • Diabetes concept graphic featuring medications, stethoscope, magnifying glass and a human torso on a grid background.
    Study reaffirms liraglutide benefits
    7/5/18

    In a larger study, patients with Type 1 diabetes also saw improvement in blood sugars and body weight.

  • Impact Study reports on a granite background.
    BEP drives economic development
    7/3/18

    UB’s Business and Entrepreneur Partnership team’s first annual impact study highlights the university’s role in WNY economic development.

  • bowl of roasted barley and glass of barley tea.
    Barley’s next great use? A medical imaging drink
    7/2/18

    A UB study finds the grain used to make beer and soup is an ideal and safe contrast agent for diagnosing swallowing disorders.

  • Google Earth view of Tonawanda, NY and the Tonawanda Coke Corp. from Grand Island.
    Enrollment begins for Tonawanda Coke study
    6/29/18

    The UB-led study will examine the impacts of plant emissions and other pollutants on the health of nearby communities.

  • Autonomous robots inspired by beavers can pick up and move blocks and beanbags.
    Rough terrain? No problem for beaver-inspired robot
    6/29/18

    Like New York’s state animal, the rover-like vehicle uses its surroundings to build complex structures and overcome obstacles.

  • driving simulator.
    Work continues with ADHD teens
    6/27/18

    GSE researcher Gregory Fabiano is using UB's driving simulator to help train adolescents with ADHD for that first job.

  • A transmission electron microscope image of zinc ferrite nanoparticles with an average diameter of 22 nanometers.
    Research on cancer-frying nanoparticles heats up
    6/27/18

    Scientists have improved the performance of magnetic nanoparticles designed to roast and destroy tumors.

  • A modified version of the hormone oxyntomodulin binds to a glucagon-like peptide-1 receptor.
    UB spinoff gets federal SBIR funding
    6/26/18

    Transira Therapeutics is developing an injectable drug that could help Type 2 diabetes patients control their blood sugar while aiding weight loss.

  • Sunset with sun rays.
    Low vitamin D levels impairs performance
    6/25/18

    The UB-led animal study is one of the few to document the impact of low levels of the “sunshine vitamin” over time.

Next> <Previous